Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Sponsors Find Benefits, Barriers in Using Real-World Evidence

  • Post author:Sam
  • Post published:September 6, 2018
  • Post category:The GMP Letter

As the FDA expands its use of real-world evidence, medical device companies are starting to explore the benefits — and the challenges. Source: The GMP Letter

Continue ReadingSponsors Find Benefits, Barriers in Using Real-World Evidence

Health Canada Updates Requirements for Class II/III Infusion Pumps

  • Post author:Sam
  • Post published:September 6, 2018
  • Post category:The GMP Letter

Citing post-market safety concerns about the delivery accuracy of infusion pumps, Health Canada is updating the evidence requirements to demonstrate the accuracy of these devices through performance testing for new…

Continue ReadingHealth Canada Updates Requirements for Class II/III Infusion Pumps

TGA Offers New Guidance on Electronic Instructions for Use

  • Post author:Sam
  • Post published:September 6, 2018
  • Post category:The GMP Letter

Australia’s Therapeutic Goods Administration issued new guidelines on electronic instructions for use for medical devices. Source: The GMP Letter

Continue ReadingTGA Offers New Guidance on Electronic Instructions for Use

FDA Pushes Back UDI Compliance Date for Combination Products

  • Post author:Sam
  • Post published:September 6, 2018
  • Post category:The GMP Letter

The FDA extended the compliance date for Global Unique Identification Database (GUDID) submission requirements for combination products, giving devicemakers another year to comply. Source: The GMP Letter

Continue ReadingFDA Pushes Back UDI Compliance Date for Combination Products

FDA Proposes Certain Device Accessories Be Defined As Class I

  • Post author:Sam
  • Post published:September 6, 2018
  • Post category:The GMP Letter

The FDA issued a list of medical device accessories that it believes are safe and effective enough to be categorized as Class I and requested public feedback on the proposed…

Continue ReadingFDA Proposes Certain Device Accessories Be Defined As Class I

FDA to Allow Combo Products to Submit Malfunction Summary Reports

  • Post author:Sam
  • Post published:September 6, 2018
  • Post category:The GMP Letter

The FDA is allowing manufacturers of combination products to submit certain device malfunction medical device reports on a quarterly basis. Source: The GMP Letter

Continue ReadingFDA to Allow Combo Products to Submit Malfunction Summary Reports

DITTA Urges FDA to Fix MDSAP Inconsistencies

  • Post author:Sam
  • Post published:September 6, 2018
  • Post category:The GMP Letter

The Global Diagnostic Imaging Healthcare IT & Radiation Therapy Trade Association is calling on the FDA and the Medical Device Single Audit Program consortium to review the program’s inconsistencies and…

Continue ReadingDITTA Urges FDA to Fix MDSAP Inconsistencies

Switzerland Overhauls Device Manufacturing Certificate Process

  • Post author:Sam
  • Post published:August 3, 2018
  • Post category:The GMP Letter

Swiss Medic will overhaul the way it issues export certificates and manufacturing certificates for devices in the fall and introduce new fees that take effect on Jan. 1, 2019. Source:…

Continue ReadingSwitzerland Overhauls Device Manufacturing Certificate Process

FDA Updates Guidance on 510(k)s for Expandable Biliary Stents

  • Post author:Sam
  • Post published:August 3, 2018
  • Post category:The GMP Letter

The FDA released new draft guidance for devicemakers on submitting premarket notifications for metal expandable biliary stents and their delivery systems. Source: The GMP Letter

Continue ReadingFDA Updates Guidance on 510(k)s for Expandable Biliary Stents

483 Roundup: FDA Cites Six Device Firms for GMP Issues

  • Post author:Sam
  • Post published:August 3, 2018
  • Post category:The GMP Letter

The FDA hit six U.S. devicemakers with 483s for problems agency investigators observed in facility inspections including inadequate risk procedures, labeling and complaint handling. Source: The GMP Letter

Continue Reading483 Roundup: FDA Cites Six Device Firms for GMP Issues
  • Go to the previous page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 44
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.